文献速递泌尿生殖与妇科肿瘤放疗

根治性前列腺切除术后接受调强放疗与三维适形放疗男性的治疗相关毒性:一项全国性人群研究

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study.
PubMed 文献 · Radiother Oncol · 2018-05-14

该研究基于英格兰国家医疗服务体系2010年1月1日至2013年12月31日数据,比较根治性前列腺切除术后接受调强放疗(IMRT,n=603)与三维适形放疗(3D-CRT,n=2422)患者的泌尿生殖(GU)和胃肠道(GI)毒性。结果显示两组GI毒性无差异,IMRT组GU毒性数值较低但未达统计学显著。作者 caution 反对在获得进一步证据前快速过渡到术后IMRT。

要点

  • 术后IMRT与3D-CRT的严重GI毒性无差异(校正HR 0.85,95%CI 0.63-1.13,p=0.26)。
  • IMRT组严重GU毒性数值较低但未达统计学显著(校正HR 0.76,95%CI 0.55-1.03,p=0.08)。
  • 作者 caution 反对在获得进一步证据前快速过渡到术后IMRT。

核心结论

  • 根治性前列腺切除术后使用IMRT compared to 3D-CRT与严重GU和GI毒性发生率无统计学显著降低相关,尽管有一些证据表明IMRT的GU毒性较低。
  • 作者 caution 反对在获得支持其优越性的进一步证据之前快速过渡到术后IMRT。

研究设计与样本

  • 一项基于人群的研究,纳入2010年1月1日至2013年12月31日在英格兰国家医疗服务体系接受根治性前列腺切除术后3D-CRT(n=2422)和IMRT(n=603)的所有患者。
  • 使用经过验证的编码框架识别严重GI和GU毒性,并采用竞争风险比例风险回归分析比较IMRT与3D-CRT。

主要发现

  • IMRT组与3D-CRT组之间GI毒性无差异(3D-CRT:5.8事件/100人年;IMRT:5.5事件/100人年;校正HR 0.85,95%CI 0.63-1.13;p=0.26)。
  • IMRT组GU毒性率较低但该效应未达统计学显著(3D-CRT:5.4事件/100人年;IMRT:3.8事件/100人年;校正HR 0.76,95%CI 0.55-1.03;p=0.08)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In the post-prostatectomy setting the value of Intensity-modulated (IMRT) relative to 3D-conformal radiotherapy (3D-CRT) in reducing toxicity remains unclear. We compared genitourinary (GU) and gastrointestinal (GI) toxicity after post-prostatectomy IMRT or 3D-CRT. MATERIALS AND METHODS: A population-based study of all patients treated with post-prostatectomy 3D-CRT (n = 2422) and IMRT (n = 603) was conducted between January 1 2010 and December 31 2013 in the English National Health Service. We identified severe GI and GU toxicity using a validated coding-framework and compared IMRT and 3D-CRT using a competing-risks proportional hazards regression analysis. RESULTS: There was no difference in GI toxicity between patients who received IMRT and 3D-CRT (3D-CRT: 5.8 events/100 person-years; IMRT: 5.5 events/100 person-years; adjusted HR: 0.85, 95%CI: 0.63-1.13; p = 0.26). The GU toxicity rate was lower with IMRT but this effect was not statistically significant (3D-CRT: 5.4 events/100 person-years; IMRT: 3.8 events/100 person-years; adjusted HR: 0.76, 95%CI: 0.55-1.03; p = 0.08). CONCLUSIONS: The use of post-prostatectomy IMRT compared to 3D-CRT is not associated with a statistically significant reduction in rates of severe GU and GI toxicity, although there is some evidence that GU toxicity is lower with IMRT. We would caution against rapid transition to post-prostatectomy IMRT until further evidence is available supporting its superiority.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Sujenthiran A, Nossiter J, Parry M, et al. Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study. Radiother Oncol. 2018. PMID: 29773442. doi:10.1016/j.radonc.2018.04.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。